Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;10(1):e001141.
doi: 10.1136/bmjgast-2023-001141.

Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease

Ming-Hsi Wang  1   2 , Jessica J Friton  2 , Laura E Raffals  2 , Jonathan A Leighton  3 , Shabana F Pasha  3 , Michael F Picco  4 , Kelly Monroe  5 , Billy D Nix  5 , Rodney D Newberry #  5 , William A Faubion #  2   3
Affiliations

Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease

Ming-Hsi Wang et al. BMJ Open Gastroenterol. 2023 Oct.

Abstract

Background: Forty distinct primary sclerosing cholangitis (PSC) genomic loci have been identified through multiancestry meta-analyses. The polygenic risk score (PRS) could serve as a promising tool to discover unique disease behaviour, like PSC, underlying inflammatory bowel disease (IBD).

Aim: To test whether PRS indicates PSC risk in patients with IBD.

Materials and methods: Mayo Clinic and Washington University at St Louis IBD cohorts were used to test our hypothesis. PRS was modelled through the published PSC loci and weighted with their corresponding effect size. Logistic regression was applied to predict the PSC risk.

Results: In total, 63 (5.6%) among 1130 patients with IBD of European ancestry had PSC. Among 381 ulcerative colitis (UC), 12% had PSC; in contrast to 1.4% in 761 Crohn disease (CD). Compared with IBD alone, IBD-PSC had significantly higher PRS (PSC risk: 3.0% at the lowest PRS quartile vs 7.2% at the highest PRS quartile, Ptrend =.03). In IBD subphenotypes subgroup analysis, multivariate analysis shows that UC-PSC is associated with more extensive UC disease (OR, 5.60; p=0.002) and younger age at diagnosis (p=0.02). In CD, multivariate analysis suggests that CD-PSC is associated with colorectal cancer (OR, 50; p=0.005).

Conclusions: We found evidence that patients with IBD with PSC presented with a clinical course difference from that of patients with IBD alone. PRS can influence PSC risk in patients with IBD. Once validated in an independent cohort, this may help identify patients with the highest likelihood of developing PSC.

Keywords: genetics; inflammatory bowel disease; primary sclerosing cholangitis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Boxplots of polygenic risk scores between PSC and non-PSC in IBD patients. IBD, inflammatory bowel disease; PSC, primary sclerosing cholangitis.
Figure 2
Figure 2
Plot of polygenic risk score quartiles and PSC status in IBD. IBD, inflammatory bowel disease; PSC, primary sclerosing cholangitis.
See this image and copyright information in PMC

References

    1. Ponsioen CY, Vrouenraets SME, Prawirodirdjo W, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002;51:562–6. 10.1136/gut.51.4.562 - DOI - PMC - PubMed
    1. Boonstra K, van Erpecum KJ, van Nieuwkerk KMJ, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2270–6. 10.1002/ibd.22938 - DOI - PubMed
    1. Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31–9. 10.1055/s-2008-1040420 - DOI - PubMed
    1. Ellinghaus D, Jostins L, Spain SL, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared Loci. Nat Genet 2016;48:510–8. 10.1038/ng.3528 - DOI - PMC - PubMed
    1. Ji S-G, Juran BD, Mucha S, et al. Genome-wide Association study of primary sclerosing cholangitis identifies new risk Loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet 2017;49:269–73. 10.1038/ng.3745 - DOI - PMC - PubMed

Publication types

MeSH terms